Maravai Lifesciences Holdings (MRVI) Invested Capital (2021 - 2026)

Maravai Lifesciences Holdings' Invested Capital history runs 6 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• On a quarterly basis, Invested Capital changed 0.0% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was $47.4 million, a 1.64% decrease from a year earlier, with the FY2025 full-year figure at $31.1 million, down 2.48% from the prior year.
• Invested Capital fell to $5.4 million in Q1 2026 per MRVI's latest filing, from $31.1 million in the prior quarter.
• Across five years, Invested Capital topped out at $34.7 million in Q1 2022 and bottomed at $5.4 million in Q3 2022.
• The 5-year median for Invested Capital is $5.4 million (2022), against an average of $17.4 million.
• Biggest YoY gain for Invested Capital was 2576.96% in 2022; the steepest drop was 84.38% in 2022.
• Year by year, Invested Capital stood at $5.4 million in 2022, then jumped by 497.98% to $32.5 million in 2023, then declined by 1.94% to $31.9 million in 2024, then slipped by 2.48% to $31.1 million in 2025, then slumped by 82.51% to $5.4 million in 2026.
• Per Business Quant, the three latest MRVI Invested Capital figures stand at $5.4 million (Q1 2026), $31.1 million (Q4 2025), and $5.4 million (Q3 2025).